DexCom Revenue vs. Price To Earning

DXCM Stock  USD 77.83  5.00  6.87%   
Taking into consideration DexCom's profitability measurements, DexCom Inc is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in December. Profitability indicators assess DexCom's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2003-12-31
Previous Quarter
B
Current Value
994.2 M
Quarterly Volatility
305.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, DexCom's Price To Sales Ratio is very stable compared to the past year. As of the 26th of November 2024, EV To Sales is likely to grow to 24.20, while Sales General And Administrative To Revenue is likely to drop 0.26. At this time, DexCom's Non Operating Income Net Other is very stable compared to the past year. As of the 26th of November 2024, Net Income Applicable To Common Shares is likely to grow to about 412 M, though Accumulated Other Comprehensive Income is likely to grow to (15.9 M).
For DexCom profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DexCom to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DexCom Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DexCom's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DexCom Inc over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.157
Earnings Share
1.65
Revenue Per Share
10.089
Quarterly Revenue Growth
0.02
Return On Assets
0.0606
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

DexCom Inc Price To Earning vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining DexCom's current stock value. Our valuation model uses many indicators to compare DexCom value to that of its competitors to determine the firm's financial worth.
DexCom Inc is rated as one of the top companies in revenue category among its peers. It also is one of the top stocks in price to earning category among its peers . The ratio of Revenue to Price To Earning for DexCom Inc is about  14,766,214 . At this time, DexCom's Total Revenue is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value DexCom by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

DexCom Revenue vs. Competition

DexCom Inc is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 3.91 Billion. DexCom totals roughly 3.62 Billion in revenue claiming about 93% of equities under Health Care industry.

DexCom Price To Earning vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

DexCom

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
3.62 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

DexCom

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
245.31 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

DexCom Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in DexCom, profitability is also one of the essential criteria for including it into their portfolios because, without profit, DexCom will eventually generate negative long term returns. The profitability progress is the general direction of DexCom's change in net profit over the period of time. It can combine multiple indicators of DexCom, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-16.7 M-15.9 M
Operating Income597.7 M627.6 M
Net Income541.5 M568.6 M
Income Tax Expense168.9 M177.3 M
Income Before Tax710.4 M745.9 M
Total Other Income Expense Net112.7 M118.3 M
Net Income From Continuing Ops541.5 M568.6 M
Non Operating Income Net Other20.7 M21.7 M
Net Income Applicable To Common Shares392.4 M412 M
Interest Income135 M141.8 M
Net Interest Income114.7 M120.4 M
Change To Netincome167.8 M84.3 M
Net Income Per Share 1.40  1.47 
Income Quality 1.38  1.45 
Net Income Per E B T 0.76  0.78 

DexCom Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on DexCom. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of DexCom position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the DexCom's important profitability drivers and their relationship over time.

Use DexCom in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DexCom position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DexCom will appreciate offsetting losses from the drop in the long position's value.

DexCom Pair Trading

DexCom Inc Pair Trading Analysis

The ability to find closely correlated positions to DexCom could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DexCom when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DexCom - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DexCom Inc to buy it.
The correlation of DexCom is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DexCom moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DexCom Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DexCom can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your DexCom position

In addition to having DexCom in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Airlines Thematic Idea Now

Airlines
Airlines Theme
Domestic and international airlines and airline services. The Airlines theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Airlines Theme or any other thematic opportunities.
View All  Next Launch
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
To fully project DexCom's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of DexCom Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include DexCom's income statement, its balance sheet, and the statement of cash flows.
Potential DexCom investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although DexCom investors may work on each financial statement separately, they are all related. The changes in DexCom's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on DexCom's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.